isoproterenol has been researched along with amlodipine in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fleckenstein, A; Fleckenstein-Grün, G; Frey, M; Zorn, J | 1 |
| Bravo, G; Hong, E; Larios, F | 1 |
| Meissner, A; Min, JY; Sandmann, S; Simon, R; Unger, T | 1 |
| Devaki, T; Ebenezar, KK; Sathish, V; Vimal, V | 1 |
| Devaki, T; Ebenezar, KK; Sathish, V | 1 |
| Haque, SE; Kohli, K; Pillai, KK; Singh, BK | 1 |
| Furuhashi, M; Fuseya, T; Hoshina, K; Ishimura, S; Mita, T; Miura, T; Moniwa, N; Shimamoto, K; Watanabe, Y; Yoshida, H | 1 |
| Abd El-Fattah, AI; Eltablawy, NA; Rashed, LA; Zaghloul, MS | 1 |
1 review(s) available for isoproterenol and amlodipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for isoproterenol and amlodipine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.
Topics: Amlodipine; Animals; Antihypertensive Agents; Arteriosclerosis; Calcium; Calcium Channel Blockers; Dihydropyridines; Heart; In Vitro Techniques; Isoproterenol; Mesenteric Arteries; Muscle, Smooth, Vascular; Myocardium; Nifedipine; Rabbits; Rats; Retinal Artery; Swine; Vasoconstriction | 1989 |
The protective action of amlodipine on cardiac negative inotropism caused by prolonged incubation in vitro.
Topics: Amlodipine; Animals; Antihypertensive Agents; Aorta; Calcium Channel Blockers; Electric Stimulation; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Potassium Chloride; Rats; Rats, Wistar; Time Factors; Ventricular Function; Ventricular Function, Right | 1998 |
Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
Topics: Adrenergic beta-Agonists; Aequorin; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic Disease; Heart; Heart Function Tests; Hemodynamics; Isometric Contraction; Isoproterenol; Male; Mibefradil; Myocardial Contraction; Myocardial Infarction; Myocardium; Papillary Muscles; Rats; Rats, Wistar; Verapamil | 1999 |
Synergistic effect of nicorandil and amlodipine on mitochondrial function during isoproterenol-induced myocardial infarction in rats.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Creatine Kinase; Drug Synergism; Isoproterenol; L-Lactate Dehydrogenase; Male; Mitochondria, Heart; Myocardial Infarction; Nicorandil; Rats; Rats, Wistar; Transaminases; Vasodilator Agents | 2002 |
Biochemical changes on the cardioprotective effect of nicorandil and amlodipine during experimental myocardial infarction in rats.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amlodipine; Animals; Cardiovascular Agents; Drug Synergism; Isoproterenol; Lipid Metabolism; Male; Mitochondria, Heart; Myocardial Infarction; Nicorandil; Oxidation-Reduction; Rats; Rats, Wistar; Succinic Acid | 2003 |
Isoproterenol-induced cardiomyopathy in rats: influence of Acorus calamus Linn.: A. calamus attenuates cardiomyopathy.
Topics: Acorus; Amlodipine; Animals; Antioxidants; Calcineurin; Cardiomyopathies; Catalase; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Isoproterenol; L-Lactate Dehydrogenase; Male; Nitric Oxide; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Rhizome; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2011 |
Angiotensin II receptor blockers decrease serum concentration of fatty acid-binding protein 4 in patients with hypertension.
Topics: 3T3 Cells; Adrenergic beta-Agonists; Amlodipine; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Fatty Acid-Binding Proteins; Female; Glucose Clamp Technique; Humans; Hypertension; Insulin; Insulin Resistance; Isoproterenol; Lipids; Male; Mice; Middle Aged | 2015 |
α-Lipoic acid and amlodipine/perindopril combination potentiate the therapeutic effect of mesenchymal stem cells on isoproterenol induced cardiac injury in rats.
Topics: Amlodipine; Animals; Drug Therapy, Combination; Heart Injuries; Isoproterenol; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Perindopril; Rats; Rats, Wistar; Thioctic Acid | 2019 |